Procellera reported raising $5 million via private placement

vomaris Procellera successfully completed a $5 million non-brokered equity financing round. A total of eight investors started to subscribe to the round one month ago. Two previous unregistered financing rounds raised an estimated $10 million.

The company is a regenerative medical device organization specializing in the bioelectrical field, generating innovative technologies for the wound care market. FDA cleared, its Procellera wound dressing is a wireless, self-contained antimicrobial wound dressing that generates a sustained electrical microcurrent at its surface when activated with a conductive fluid.

The company, headquartered in Tempe AZ, is led by Michael Nagel (CEO). Revenues on or below $1 million were reported by Procellera.
The executive team includes Jeff Stevens, Jeffry Skiba, Mary Maijer, Michel Tanguay, Paul Foster, Sandra Mendez and Scott Weaver.
The board of directors includes Eugene Schneller.

The company has raised an estimated total of $15 million via private unregistered security offerings.

Procellera is registered under the name Vomaris Innovations

Offering recap
Status: Completed
Company: Procellera
Industry: Other Health Care
Amount offered: $5 million
Amount placed: $5 million
First sale: 09-12-2014
Data as of: 10-20-2014

For more information visit


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s